News Related to Oropharyngeal Cancer

Related coverage linked through entity extraction aliases.

Immunotherapy, Targeted Therapy, and mRNA Vaccines Reshaping Cancer Care

May 07, 2026

Cancer care is being transformed by targeted therapy, immunotherapy, personalized medicine, and emerging mRNA-based universal cancer vaccines. Advances in immunotherapeutics and cellular therapies are improving survival rates, while an off-the-shelf mRNA vaccine from the University of Florida is already in human trials.

Immunotherapy Fails to Improve Survival in Two Cancer Trials

Mar 13, 2026

Two recent clinical trials found that adding immunotherapy to standard chemoradiation did not improve survival for patients with limited-stage small-cell lung cancer or high-risk HPV-positive oropharyngeal cancer, though both studies revealed important insights about treatment delivery and radiation scheduling.